Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Preferred Dividend Payments (2022 - 2025)

Historic Preferred Dividend Payments for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $90000.0.

  • PAVmed's Preferred Dividend Payments changed N/A to $90000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $349000.0, marking a year-over-year change of. This contributed to the annual value of $329000.0 for FY2024, which is 822.37% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's Preferred Dividend Payments is $90000.0.
  • PAVmed's 5-year Preferred Dividend Payments high stood at $90000.0 for Q3 2025, and its period low was $68000.0 during Q1 2022.
  • In the last 4 years, PAVmed's Preferred Dividend Payments had a median value of $77500.0 in 2023 and averaged $78214.3.
  • Its Preferred Dividend Payments has fluctuated over the past 5 years, first soared by 714.29% in 2023, then soared by 897.44% in 2024.
  • PAVmed's Preferred Dividend Payments (Quarter) stood at $72000.0 in 2022, then increased by 8.33% to $78000.0 in 2023, then rose by 8.97% to $85000.0 in 2024, then increased by 5.88% to $90000.0 in 2025.
  • Its last three reported values are $90000.0 in Q3 2025, $88000.0 for Q2 2025, and $86000.0 during Q1 2025.